BJO

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Luksch, A
Right arrow Articles by Schmetterer, L
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Luksch, A
Right arrow Articles by Schmetterer, L
British Journal of Ophthalmology 2005;89:21-25
© 2005 BMJ Publishing Group Ltd


SCIENTIFIC REPORT

Effect of nimodipine on ocular blood flow and colour contrast sensitivity in patients with normal tension glaucoma

A Luksch1,2, G Rainer1, D Koyuncu1, P Ehrlich2, T Maca3, M E Gschwandtner3, C Vass1, L Schmetterer2,4

1 Department of Ophthalmology and Optometry, University of Vienna, Vienna, Austria
2 Department of Clinical Pharmacology, University of Vienna, Vienna, Austria
3 Department of Angiology, University of Vienna, Vienna, Austria
4 Institute of Medical Physics, University of Vienna, Vienna, Austria

Correspondence to:
Correspondence to:
Dr G Rainer
Department of Ophthalmology, Währinger Gürtel 18–20, A-1090 Vienna, Austria; georg.rainer{at}akh-wien.ac.at


ABSTRACT
Aim: To investigate the effects of oral nimodipine on ocular haemodynamic parameters and colour contrast sensitivity in patients with normal tension glaucoma (NTG).

Design: The study was performed in a randomised, placebo controlled, double masked, crossover design.

Participants: Nimodipine (60 mg) or placebo was administered to 14 consecutive NTG patients.

Methods: The effects or oral nimodipine or placebo on ocular and systemic haemodynamic parameters and colour contrast sensitivity along the tritan axis were studied two hours after administration. Optic nerve head blood flow (ONHBF) and choroidal blood flow (CHBF) were assessed with laser Doppler flowmetry. Ocular fundus pulsation amplitude (FPA) was measured with laser interferometry. Colour contrast sensitivity (CCS) was determined along the tritan colour axis.

Main outcome measures: ONHBF, CHBF, FPA, intraocular pressure and CCS were assessed in patients with NTG.

Results: Mean ocular FPA increased by 14% (SD 14%) (p = 0.0008), ONHBF by 18% (SD 16%) (p = 0.0031), and CHBF by 12% (SD 14%) (p<0.001) after administration of nimodipine. Nimodipine also decreased the threshold of colour contrast sensitivity along the tritan colour axis (–14% (SD 12%); p = 0.048). However, individual changes in FPA, ONHBF, or CHBF were not correlated with changes in threshold of CCS along the tritan colour axis.

Conclusions: The results indicate that nimodipine increases ONH and choroidal blood flow in NTG patients and improves CCS. The latter effect does not, however, seem to be a direct consequence of the blood flow improvement.


Abbreviations: CHBF, choroidal blood flow; DSPS, Doppler shift power spectrum; ET-1, endothelin-1; FPA, fundus pulsation amplitude; IOP, intraocular pressure; LDF, laser Doppler flowmetry; NTG, normal tension glaucoma; ONHBF, optic nerve head blood flow; RBCs, red blood cells

Keywords: calcium channel blockers; normal tension glaucoma; ocular blood flow; optic nerve head blood flow; colour contrast sensitivity




This article has been cited by other articles:


Home page
IOVSHome page
G. Michelson, S. Warntges, S. Leidig, J. Lotsch, and G. Geisslinger
Nimodipine plasma concentration and retinal blood flow in healthy subjects.
Invest. Ophthalmol. Vis. Sci., August 1, 2006; 47(8): 3479 - 3486.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2005 by the BMJ Publishing Group Ltd.